Vincent Charles Marconi

Vanderbilt University Medical Center

NIH Rank #624
  • Top 5% Funded
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#624
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $7M across 3 grants · National rank #624.

Top grants by award amount

Vincent Charles Marconi's NIH grant portfolio, ranked by award amount.

  • 1R01AG085873-01R01
    REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
    $5.7M
    award amount
  • 5R01DK125187-05R01
    Multi-omic Predictors of Renal Function among HIV-infected Individuals of African Ancestry
    $730.2K
    award amount
  • 5R01MH128158-03R01
    Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system
    $638.4K
    award amount

Affiliations

Institutions that have administered grants for Vincent Charles Marconi.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Vanderbilt University Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #624
  7. 2024
    Entered Top 25% Nationally
    Ranked #624
  8. 2024
    Entered Top 10% Nationally
    Ranked #624
  9. 2024
    Entered Top 5% Nationally
    Ranked #624
  10. 2024
    Multi-Institutional Research
    Awards at 2 institutions